Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$NMRA . Trades below CASH. 7 drugs in pipeline. Recently took a 80% haircut on bad initial data on one of three phase III. Oversold. RSI low. Bounce.
nmra...................................under 2
NMRA........................https://stockcharts.com/h-sc/ui?s=NMRA&p=W&b=5&g=0&id=p86431144783
NMRA.............................................https://stockcharts.com/h-sc/ui?s=NMRA&p=W&b=5&g=0&id=p86431144783
nmra..........................under 2.00
1.95 -81%
$NMRA P2b retrospective data mining in shock turn of events doesn't translate to prospective P3 stat sig data. What a surprise.— Biotech Shoutouts (@BiotechSho99376) January 2, 2025
$NMRA P2b retrospective data mining in shock turn of events doesn't translate to prospective P3 stat sig data. What a surprise.
$NMRA right to cash level, same drug bi polar next pic.twitter.com/nfXRhMULQH— MonkeyGenius (@bearsbounce) January 2, 2025
$NMRA right to cash level, same drug bi polar next pic.twitter.com/nfXRhMULQH
$NMRA whiff - pic.twitter.com/y0cVEhb2fN— Sports_Bios (@Sports_bios) January 2, 2025
$NMRA whiff - pic.twitter.com/y0cVEhb2fN
NMRA under $15
NMRA under $10
NMRA under &10
InvestorsHub community
Register for free to join our community of investors and share your ideas
You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads